<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Kidneys play an important role in <z:chebi fb="1" ids="50211">retinol</z:chebi> turnover </plain></SENT>
<SENT sid="1" pm="."><plain>We postulated that <z:chebi fb="1" ids="50211">retinol</z:chebi> homeostasis is disturbed in diabetic <z:hpo ids='HP_0000112'>nephropathy</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>The aim of this research was to study the effect of kidney impairment on urinary excretion and on serum concentrations of <z:chebi fb="1" ids="50211">retinol</z:chebi> in type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> patients </plain></SENT>
<SENT sid="3" pm="."><plain>For this purpose, 41 type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> patients and 9 sex -and age-matched healthy subjects were enrolled </plain></SENT>
<SENT sid="4" pm="."><plain>Serum and urinary <z:chebi fb="1" ids="50211">retinol</z:chebi> and <z:chebi fb="1" ids="50211">retinol</z:chebi>-binding protein (RBP) were assessed by high-pressure liquid chromatography and enzyme-linked immunosorbent assay, respectively </plain></SENT>
<SENT sid="5" pm="."><plain>The study showed that 17 out of 41 diabetic patients (41.5%) and none of the controls excreted <z:chebi fb="1" ids="50211">retinol</z:chebi> in urine (P &lt; 0.02) </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="1" ids="50211">Retinol</z:chebi> excretion in the urine in these patients was 1.5-fold more prevalent than <z:e sem="disease" ids="C1328315" disease_type="Disease or Syndrome" abbrv="">hypercreatininemia</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>Urinary <z:chebi fb="1" ids="50211">retinol</z:chebi> significantly correlated with clinically diagnosed <z:hpo ids='HP_0000112'>nephropathy</z:hpo> (P = 0.02) </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> but one of the patients with <z:e sem="disease" ids="C1328315" disease_type="Disease or Syndrome" abbrv="">hypercreatininemia</z:e> excreted <z:chebi fb="1" ids="50211">retinol</z:chebi> in the urine </plain></SENT>
<SENT sid="9" pm="."><plain>Serum <z:chebi fb="1" ids="50211">retinol</z:chebi> and RBP in patients with <z:e sem="disease" ids="C1328315" disease_type="Disease or Syndrome" abbrv="">hypercreatininemia</z:e> were higher than in controls (P &lt; 0.002) </plain></SENT>
<SENT sid="10" pm="."><plain>Values of urinary <z:chebi fb="1" ids="50211">retinol</z:chebi>, unlike urinary RBP, albumin and total protein, did not overlap between patients and controls </plain></SENT>
<SENT sid="11" pm="."><plain>Our results indicate that (i) urinary <z:chebi fb="1" ids="50211">retinol</z:chebi> is a specific sign of tubular damage in type 2 diabetic patients and (ii) urinary <z:chebi fb="1" ids="50211">retinol</z:chebi> enables a more clear-cut identification of <z:hpo ids='HP_0000114'>proximal tubule dysfunction</z:hpo> in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> patients than urinary RBP or albumin </plain></SENT>
</text></document>